PASADENA – The World Stem Cell Summit, now in its seventh year, will kick off three days of networking and seminars on Monday at the Pasadena Convention Center in hopes of spurring progress and investment in the emerging industry. The event promises more than 150 top international speakers and 50 hours of programming with industry leaders from science, pharmaceuticals, business, policy, ethics, law and more. Bernie Siegel, founder and co-chair of the Summit and executive director the Genetic Policy Institute (GPI), which produces the event, said this year’s focus on translational regenerative medicine is about asking “how do you take the phenomenal scientific research going on in labs and translate it into medical treatments? It’s a big job to do this, and more than just the science.”
Recent Posts
- Do stem-cell transplants increase cancer risk? Long-lived recipients offer clues
- Re-engineered, blue light-activated immune cells penetrate and kill solid tumors
- Microenvironment-responsive nanomedicines: a promising direction for tissue regeneration
- Life Without Sickle Cell Beckons Boy Who Completed Gene Therapy
- Neuroscientists discover a mechanism that can reactivate dormant neural stem cells
- Human skin map gives ‘recipe’ to build skin and could help prevent scarring